Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review

Biomolecules(2021)10.3390/biom11121819Source: DataRank Database

The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review is a research paper published in Biomolecules (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (40)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Thinzar M. Lwin ORCID,Siamak Amirfakhri ORCID,Hiroto Nishino ORCID,Robert M. Hoffman ORCID,Paul J. Yazaki ORCID

Live enrichment

PubMed:34944463 PMC:PMC8699160

United States Department of Veterans Affairs

Grant: 1 I01 BX003856-01A1 and 1 I01 BX004494-01

National Institutes of Health

Grant: T32CA121938

National Institutes of Health

Grant: 5T32CA121938-14

UCSD Cancer Center Training Program in Drug Development

National Institutes of Health

Grant: 5I01BX003856-04

Development of Near Infrared Fluorescence-Guided Surgical Navigation and Tumor Specific Photoimmunotherapy for Improved Outcomes for GI Cancers

goldLicense: cc-by

publisherhttps://www.mdpi.com/2218-273X/11/12/1819/pdf?version=1638523113

publisherhttps://www.mdpi.com/2218-273X/11/12/1819/pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8699160

repositoryhttps://doaj.org/article/b484615bd8594fab9537b7e3920a5ed9

repositoryhttps://escholarship.org/uc/item/7c85n63z

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsHumansNeoplasmsCarcinoembryonic AntigenAntibodiesFluorescent Dyes

Keywords

Fluorescence labelingCarcinoembryonic antigenFluorescenceCEAFluorescence-guided SurgeryFgsInfrared DyesOncology and CarcinogenesisMedical biotechnology610BioengineeringReviewGPI-Linked ProteinsMicrobiologyAntibodiesPancreatic CancerRare DiseasesNeoplasmsMonoclonalHumansAnimalsCancerFluorescent DyesBiomedical and Clinical SciencesPreventionOptical ImagingBioinformatics and computational biologyQR1-502Colo-Rectal CancerBiochemistry and cell biologyDigestive DiseasesBiotechnology

Sustainable Development Goals

SDG 3: 3. Good health

The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review

FAIR Checklist

Authors (7)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)